Farmaceutica REMEDIA Income Statement

Financials in millions RON. Fiscal year is January - December.

Millions RON. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	759.76	743.79	593.36	535.85	477.1
Other Revenue	0.98	3.23	-	-	-
Revenue	760.74	747.02	593.36	535.85	477.1
Revenue Growth (YoY)	1.84%	25.90%	10.73%	12.31%	8.07%
Cost of Revenue	720.41	705.14	558.54	500.19	447.83
Gross Profit	40.33	41.88	34.82	35.66	29.27
Selling, General & Admin	24.75	25.36	20.62	22.13	19.47
Amortization of Goodwill & Intangibles	2.41	2.63	5.06	4.02	-
Other Operating Expenses	-0.59	0.79	2.38	3.08	0.32
Operating Expenses	26.56	28.78	28.06	29.23	21
Operating Income	13.77	13.1	6.76	6.43	8.28
Interest Expense	-0.05	-0.1	-0.12	-0.16	-0.11
Interest & Investment Income	1.33	1.25	0.94	0.47	0.16
Earnings From Equity Investments	0.25	-0.11	-0.28	-	-
Currency Exchange Gain (Loss)	-0.34	-0.16	-0.04	-0.08	-0.06
Other Non Operating Income (Expenses)	0.35	0.11	0.35	0.13	-0.14
EBT Excluding Unusual Items	15.31	14.09	7.6	6.79	8.13
Gain (Loss) on Sale of Assets	0.9	-	1.31	0.27	0.51
Pretax Income	16.21	14.09	8.91	7.06	8.63
Income Tax Expense	8.17	7.13	1.71	1.25	1.4
Net Income	8.04	6.96	7.2	5.81	7.23
Net Income to Common	8.04	6.96	7.2	5.81	7.23
Net Income Growth	15.45%	-3.33%	23.97%	-19.69%	-80.85%
Shares Outstanding (Basic)	95	96	96	96	95
Shares Outstanding (Diluted)	95	96	96	96	95
Shares Change (YoY)	-0.04%	-0.01%	-0.03%	0.13%	-10.06%
EPS (Basic)	0.08	0.07	0.08	0.06	0.08
EPS (Diluted)	0.08	0.07	0.08	0.06	0.08
EPS Growth	15.50%	-3.32%	24.01%	-19.79%	-78.71%
Free Cash Flow	14.22	17.17	21.84	-2.03	2.59
Free Cash Flow Per Share	0.15	0.18	0.23	-0.02	0.03
Dividend Per Share	0.050	0.040	0.050	0.050	0.050
Dividend Growth	25.00%	-20.00%	-	-	-66.67%
Gross Margin	5.30%	5.61%	5.87%	6.65%	6.14%
Operating Margin	1.81%	1.75%	1.14%	1.20%	1.74%
Profit Margin	1.06%	0.93%	1.21%	1.08%	1.52%
Free Cash Flow Margin	1.87%	2.30%	3.68%	-0.38%	0.54%
EBITDA	15.82	15.73	10.89	10.45	9.14
EBITDA Margin	2.08%	2.10%	1.84%	1.95%	1.92%
D&A For EBITDA	2.05	2.63	4.12	4.02	0.86
EBIT	13.77	13.1	6.76	6.43	8.28
EBIT Margin	1.81%	1.75%	1.14%	1.20%	1.74%
Effective Tax Rate	50.42%	50.60%	19.16%	17.69%	16.22%
Revenue as Reported	763.55	747.02	598.28	539.2	477.95
Advertising Expenses	0.05	0.18	0.12	0.05	0.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.